Doximity (DOCS) Director Regina Benjamin Receives RSU Award

What Happened

• Regina M. Benjamin, a director of Doximity, was granted 9,750 restricted stock units (RSUs) on November 15, 2025 (reported as an Award/Grant, code A). The reported grant price is $0.00 (RSUs are contingent rights rather than an immediate cash purchase), so the reported acquisition value is $0.
• The filing amends and replaces the original Form 4 filed November 18, 2025: the Compensation Committee determined that 21,314 of the 31,064 RSUs originally reported were not validly granted and were void ab initio, leaving 9,750 RSUs as the valid grant. Each RSU represents a contingent right to receive one share of Class A common stock upon vesting.

Key Details

• Transaction date: November 15, 2025; reported in an amended Form 4/A filed July 14, 2026.
• Price: $0.00 per RSU (award), total reported acquisition value $0.
• Vesting schedule for the 9,750 RSUs (subject to continued service): 3,106 RSUs on Feb 15, 2026; 3,107 RSUs on May 15, 2026; 3,106 RSUs on Aug 15, 2026; 431 RSUs on Nov 15, 2026.
• Notable footnote: Compensation Committee voided 21,314 of the initially reported 31,064 RSUs as not validly granted under the 2021 Plan; this amendment reports only the 9,750 RSUs deemed valid.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Filing status: This is an amendment (Form 4/A) correcting the original November 18, 2025 filing.

Context

• RSUs are a compensation award that convert into shares only upon vesting; they are not an open-market purchase or sale and do not necessarily reflect immediate insider buying/selling sentiment.
• Taxes or share withholding may apply at vesting (not detailed in this filing). This amendment is primarily an administrative correction reflecting the Compensation Committee’s determination about which RSUs were validly granted.